Cynosure Receives Approval to Market SculpSure® in South Korea
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Brean Capital Raises Price Target as Cynosure (CYNO) Delivers Strong 2Q Results
July 27, 2016 10:58 AM EDTBrean Capital reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $54.00), following the company's 2Q earnings report. Revenue was $110.3 million vs. consensus of $101.3 million. The growth was driven primarily by product expansion in North America. Non-GAAP EPS came in... More
Northland Capital Markets Raises Price Target on Cynosure (CYNO) to $60 Following 2Q
July 27, 2016 10:41 AM EDTNorthland Capital Markets reiterated an Outperform rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $55.00), following the company's 2Q earnings report. CYNO reported revenues of $110M, coming in ahead of the Street's $102M estimates. EPS of $0.27 was also above estimates.... More
